首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4356篇
  免费   376篇
  国内免费   2篇
  2023年   39篇
  2022年   23篇
  2021年   163篇
  2020年   92篇
  2019年   137篇
  2018年   149篇
  2017年   98篇
  2016年   204篇
  2015年   308篇
  2014年   335篇
  2013年   333篇
  2012年   436篇
  2011年   451篇
  2010年   236篇
  2009年   205篇
  2008年   274篇
  2007年   284篇
  2006年   211篇
  2005年   187篇
  2004年   144篇
  2003年   122篇
  2002年   114篇
  2001年   20篇
  2000年   14篇
  1999年   19篇
  1998年   16篇
  1997年   8篇
  1996年   4篇
  1995年   8篇
  1994年   5篇
  1993年   4篇
  1992年   5篇
  1991年   3篇
  1990年   3篇
  1989年   5篇
  1987年   3篇
  1986年   4篇
  1985年   6篇
  1983年   5篇
  1982年   7篇
  1981年   3篇
  1980年   3篇
  1977年   2篇
  1973年   2篇
  1966年   2篇
  1962年   2篇
  1961年   3篇
  1960年   3篇
  1955年   4篇
  1911年   2篇
排序方式: 共有4734条查询结果,搜索用时 234 毫秒
991.
Radical mastectomy is excellent only for cases of operable breast cancer in which the tumor is limited to the breast or to the nodes in the axilla. That there is metastasis to the internal mammary lymph nodes in a high proportion of cases has been “overlooked” for many years. Also it is probable that metastasis occurs to the supraclavicular lymph nodes more often than is suspected. Hence the extended radical mastectomy operation leaves much to be desired. There has been no significant improvement in recent years in the mortality rate of mammary cancer.Simple mastectomy and thorough adequate postoperative radiation therapy have much to offer.Treatment of “operable” breast cancer should be a cooperative effort of surgeon, radiation therapist and pathologist.  相似文献   
992.
993.
994.
995.
996.
997.
998.
Cortical bone allografts suffer from high rates of failure due to poor integration with host tissue, leading to non‐union, fracture, and infection following secondary procedures. Here, we report a method for modifying the surfaces of cortical bone with coatings that have biological functions that may help overcome these challenges. These chitosan‐heparin coatings promote mesenchymal stem cell attachment and have significant antibacterial activity against both S. aureus and E. coli. Furthermore, their chemistry is similar to coatings we have reported on previously, which effectively stabilize and deliver heparin‐binding growth factors. These coatings have potential as synthetic periosteum for improving bone allograft outcomes. Biotechnol. Bioeng. 2013; 110: 609–618. © 2012 Wiley Periodicals, Inc.  相似文献   
999.
1000.
The non-coding small RNA, IhtA expressed by the obligate intracellular human pathogen Chlamydia trachomatis modulates the translation of HctA, a key protein involved in replicative to infectious cell type differentiation. Using a combination of bioinformatics and mutagenesis we sought to identify the base pairing requirement for functional repression of HctA protein expression, with an eye to applying our findings towards the identification of additional targets. IhtA is predicted to fold into a three stem:loop structure. We found that loop 1 occludes the initiation codon of hctA, while loop 2 and 3 are not required for function. This 7 nucleotide region forms G/C rich interactions surrounding the AUG of hctA. Two additional genes in the chlamydial genome, CTL0322 and CTL0097, contained some elements of the hctA:IhtA recognition sequence. The mRNA of both CTL0322and CTL0097 interacted with IhtA in vitro as measured by biolayer interferometry. However, using a CheZ reporter expression system, IhtA only inhibited the translation of CTL0322. The proposed IhtA recognition site in the CTL0322 message contains significant G/C base pairing on either side of the initiation codon while CTL0097 only contains G/C base pairing 3’ to the AUG initiation codon. These data suggest that as the functional interacting region is only 6-7nt in length that full translation repression is dependent on the degree of G/C base pairing. Additionally our results indicate that IhtA may regulate multiple mRNAs involved in the chlamydial infectious cycle.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号